Boundless Bio Inc.
BOLD
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.6M
Close$
$-1.39
150.2% downside
Current Fair Value
150.2% downsideOvervalued by 150.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $63.60 Million |
|---|---|
| Enterprise Value | $43.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.6 |
| Beta | 0.38 |
| Outstanding Shares | 22,450,000 |
Return
| Return on Equity | -97.02% |
|---|---|
| Return on Assets | -86.80% |
| Return on Invested Capital | -107.11% |
Valuation & Multiples
| P/E Ratio | -0.99 |
|---|---|
| PEG | -1.93 |
| Price to Sales | - |
| Price to Book Ratio | 1.39 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.61 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-1.06
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 37.87%▼ 1.40% |
|---|---|
| Total Invested | $9.33M▼ 11.42% |
| Investors Holding | 36▲ 1.00% |
ESG Score
No data